These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16506366)
21. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139 [TBL] [Abstract][Full Text] [Related]
22. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. Margel D; Tal R; Baniel J J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837 [TBL] [Abstract][Full Text] [Related]
23. CEACAM1, a novel serum biomarker for pancreatic cancer. Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843 [TBL] [Abstract][Full Text] [Related]
24. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064 [TBL] [Abstract][Full Text] [Related]
25. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract]. Takami H; Furuuchi T; Ogata Y; Abe O Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885 [TBL] [Abstract][Full Text] [Related]
26. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI. Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039 [TBL] [Abstract][Full Text] [Related]
27. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Liao WC; Wu MS; Wang HP; Tien YW; Lin JT Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of CA 15-3 radioimmunoassay]. Takemori Y; Odani H; Watanabe H; Ohta H; Satomura Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654 [TBL] [Abstract][Full Text] [Related]
29. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract]. Takami H; Furuuchi T; Ogata Y; Abe O Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958 [TBL] [Abstract][Full Text] [Related]
30. [A predictive model for pancreatic cancer using serum protein footprint map]. Long J; Di Y; Jin C; Yu XJ; Liu WW; Chen YM; Fu DL; Ni QX Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1533-6. PubMed ID: 18956633 [TBL] [Abstract][Full Text] [Related]
31. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers]. Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791 [TBL] [Abstract][Full Text] [Related]
32. Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer. Vormittag L; Gleiss A; Scheithauer W; Lang F; Laengle F; Kornek GV Oncology; 2009; 77(2):140-6. PubMed ID: 19628952 [TBL] [Abstract][Full Text] [Related]
33. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1. Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485 [TBL] [Abstract][Full Text] [Related]
34. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916 [TBL] [Abstract][Full Text] [Related]
35. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021 [TBL] [Abstract][Full Text] [Related]
36. Urinary gonadotropin peptide in patients with cancer of digestive organs. Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740 [TBL] [Abstract][Full Text] [Related]
37. CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Koom WS; Seong J; Kim YB; Pyun HO; Song SY Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1148-54. PubMed ID: 18760544 [TBL] [Abstract][Full Text] [Related]
38. [A basic and clinical study of CA 19-9-MP-Mitsui kit for determination of CA 19-9]. Ishii M; Iida M; Seino Y Gan To Kagaku Ryoho; 1994 Dec; 21(16):2779-86. PubMed ID: 7993114 [TBL] [Abstract][Full Text] [Related]
39. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer. Wu D; Qian JM; Deng RX; Jiang WJ; Chen YJ; Liu XH; Lu XH Chin J Dig Dis; 2006; 7(2):117-20. PubMed ID: 16643340 [TBL] [Abstract][Full Text] [Related]
40. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Guo Q; Zhang B; Dong X; Xie Q; Guo E; Huang H; Wu Y Pancreas; 2009 Apr; 38(3):e75-9. PubMed ID: 19276866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]